Tip of the iceberg: here's an article about how a corrupt doctor on a clinical trial leaked information that enabled SAC to make 276 effing MILLION BUCKS trading.

http://dealbook.nytimes.com/2014/01/17/key-wi...h_20140118

Anyone think this is the only case like this?

We have SO often seen frontrunning of smaller biotechs, and then news comes out. So a trader friend of mine who disregards anything but direction and volume may have the right idea.